Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

NCT03511196 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Stage IV Prostate Cancer
Advanced Prostate Cancer
Adenocarcinoma of the Prostate

Interventions

DRUG: Adaptive Androgen Deprivation Therapy (ADT)
DRUG: Abiraterone
DRUG: Prednisone

Sponsor

H. Lee Moffitt Cancer Center and Research Institute